Depression

CBT for Chronic Gastrointestinal Disorders: They’re More Common Than You Think!
October 16, 2024
Melissa G. Hunt, PhD and
This workshop covers what is known about the etiology and symptoms of IBS, how IBS patients present in clinical practice; IBS in the context of co-morbid panic and agoraphobia, social anxiety disorder, ARFID and depression.
Communicating With Challenging Patients and Their Families
April 25, 2024
Lawrence Amsel, MD and
This April 25 live CE eligible webinar with Dr. Lawrence Amsel will focus on methods for improving communication and engagement and developing strategies that will avoid common misunderstandings in these clinical situations and improve both clinical efficiency and patient outcomes.
The Role of Caregivers in Interventions for Youth Depression and Suicidality
July 11, 2022
Alex Bettis, PhD and
Kirsty Clark, PhD, MPH and
Autumn Kujawa, PhD and
Jessica M. Schwartzman, PhD and

Nutraceuticals and Herbs for Depression and Anxiety
April 21, 2022
David Mischoulon, MD, PhD and
The presentation will review selected nutraceutical and herbal remedies that are used for treating depression and anxiety.
DBS for Depression - Webinar
February 15, 2022
Sameer Sheth, MD, PhD and
This webinar provides an overview of the history of DBS for TRD, focusing on the last 10 years of effort. During this time, there have been a number of open label and randomized controlled trials that have shed light on this therapy. The webinar also discusses current trials in this field.
Psilocybin-assisted Psychotherapy - Mood Disorder Treatment
January 27, 2022
Greg Fonzo, PhD and
There is a recent and growing resurgence of interest in the potential for psychedelic compounds to be utilized as treatments for mood and anxiety disorders. Learn about a broad overview of the history, current clinical practice, and potential therapeutic mechanisms underlying psilocybin-assisted psychotherapy.
2021 Fall Forum: Depression Across the Lifespan
October 21, 2021
Alan F. Schatzberg, MD and
Gabriela Livas Stein, PhD and
Namkee Choi, PhD and
Shawn Jones, PhD, MHS and
Gabrielle Liverant, PhD and
David Mischoulon, MD, PhD and
Barbara Kamholz, PhD, ABPP Senior Advisor, Professional Education  and
ADAA's annual Fall Forum - eligible for 2-3 CE/CME credits brought together a panel of renowned experts in an engaging and interactive presentation.
Medical Marijuana Laws & Evidence for Harmful/Beneficial Effects in Depression and Anxiety Disorders
May 28, 2020
Treating Anxiety and Depression in Gender Diverse Populations
June 3, 2020
Lauren P. Wadsworth, PhD and
This webinar discusses population specific components of anxiety and depression development (e.g. role of stigma, coming out), and provides tangible ways to provide more accurate and affirming research, and/or more culturally informed therapy.